APPLICATIONS PUBLISHED 29 SEPTEMBER 2004
Published: 1-Apr-2005
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Stabilised reverse micelle compsns and uses thereof
Dor Biopharma 1460992*
Compounds for a controlled release of active molecules
Firmenich 1460994*
Transdermal transport of compounds
Vital Health Sciences 1460995*
Novel N-4-(1-H-imidazol-1-yl)-2-fluorophenyl]-3-(trifluoromethyl)-1-H-pyrazole-5-carboxamides as factor XA
Bristol-Myers Squibb 1460996*
Methods for the purification of levofloxacin
Teva Pharmaceutical Industries 1460997*
Extended release pharmaceutical tablet of metformin
Bioavail Laboratories 1460998*
Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin-3,3'-digallate and mixtures thereof
Nashai Biotech 1460999*
Materials and methods for improved micelle compsns
The Board of Trustees of the University of Illinois 1461000*
Cancer-associated epitope
The Scripps Research Institute 1461001*
Method of producing a nicotine compsn
Thompson, Marshall 1461013*
Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting
Ben Gurion University of the Negev Research & Development Authority 1461014*
Compsns containing both sedative and non-sedative antihistamines
Peirce Management 1461015*
Modular systems for the controlled release of a substance with space and time control
Universita' degli studi di Parma 1461016*
A pharmaceutical compsn for controlled release of a beta-lactam antibiotic
Lupin 1461017*
Dual controlled release dosage form
Osmotica 1461018*
Bioadhesive drug delivery system with enhanced gastric retention
Spherics 1461019*
Synthesis of small particles
Eiffel Technologies 1461020*
Transdermal drug delivery system of strychnine, brucine, securinine and their salts
Zhang, Xitian 1461021*
Use of selective PDE5 inhibitors for treating partial and global respiratory failure
Altana Pharma 1461022*
Prospective identification and characterisation of breast cancer stem cells
The Regents of the University of Michigan 1461023*
Treatment of wounds and compsns employed
Greystone Medical Group 1461024*
Treatment of neurodegenerative and cardiovascular disorders
Du, Yangsheng 1461025*
Method for treating ocular hypertension
Merck; Merck Frosst Canada 1461026*
Treatment of neoplasia
Virginia Commonwealth University 1461027*
Treatment for age-related macular degeneration
The Regent of the University of California 1461028*
Taxane-based compsns and methods of use
Ivax Research 1461029*
Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma
Alcon 1461030*
Formations for oral administration of cromolyn sodium
Emisphere Technologies 1461031*
Use of tyrosine kinase inhibitors for promoting hair growth
AB Science 1461032*
Methods and compsns for ameliorating the undesirable effects of chemotherapy
Sound Pharmaceuticals Inc 1461033*
Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines
Aventis Pharma Deutschland 1461034*
Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
Bristol-Myers Squibb 1461035*
Bis hydrochloride monohydrate salt of RSV fusion inhibitor
Bristol-Myers Squibb 1461036*
Beverage treated with nicotine
Knight, Joseph Robert 1461037*
Arylsulphonamide derivatives for use as CCR3 antagonists in the treatment of inflammatory and immunological disorders
Bayer HealthCare 1461038*
Pharmaceutical compsns comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor
Otsuka Pharmaceutical 1461039*
Succinic acid salts of 5,8,14-triazatetrocyclo[[10.3.1.0.2,11.0.4.9]-hexadeca-2(11),35,7,9-pentaene and pharmaceutical compsns thereof
Pfizer Products 1461040*
Preparation of the intermediates useful in the synthesis of antiviral nucleosides
Pharmasset 1461041*
Use of desoxypeganine for treating clinical depression
HF Arzneimittelforschung 1461042*
Oral pharmaceutical products containing 17-beta-estradiol-3 lower alkanoate, method of administering the same and process of preparation
Galen (Chemicals) 1461043*
Pharmaceutical compsns comprising active vitamin D compounds
Novacea 1461044*
Glucosamine organic acid adducts
Cargill 1461045*
Fluorinated glucosamine analogues useful for modulating post-translational glycosylations on cells
The Brigham & Women's Hospital 1461046*
Compsns and methods for animal treatment
Vitalan 1461047*
Buffalo milk gangliosides
Societe des Produits Nestle 1461048*
Use of sulphated glycosaminoglycans for establishing effective labour in women
Karolinska Innovations 1461049*
Oral immunostimulation of mammals, birds and reptiles from (1-4) linked beta-D-mannuronic acid
FMC Biopolymer 1461050*
Compsns incorporating (-)-hydroxycitric acid, chromium, and gymnemic acid, and related methods for promoting healthy body weight and improving related health factors
Interhealth Nutraceuticals 1461051*
Nucleic acid injected into hepatic vein lumen and delivered to primate liver
Mirus Corp 1461052*
Storage-stable fibrin sealant
Woolverton, Christopher J 1461053*
Gram-positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
Institut Pasteur 1461054*
Anti-bacterial plant compsns
Inter American University of Puerto Rico 1461055*
Method for preparing and using polyoxylated castor oil in pharmaceutical compsns
SuperGen 1461056*
A topical anti-itch formulation and a process for the preparation thereof
Johnson & Johnson 1461057*
Supplements containing annatto extracts and carotenoids and methods for using the same
Levy, Pedro 1461058*
Active substances for use in cosmetic and/or pharmaceutical products, obtainable from the fermentation of plant components and/or plant extracts
Cognis France 1461059*
Compsns and methods for detecting and treating diseases and conditions related to chemokine receptors
Chemocentryx 1461061*
Compsn and method for treating chronic allograft rejection
The Scripps Research Institute 1461062*
Treatment of glioblastoma with thymosin-alpha-1
Rhode Island Hospital 1461063*
Bovine leptin protein, antisense and antibody
Purina Mills 1461064*
Erythropoietin dosing regimen for treating anaemia
Ortho-McNeil Pharmaceutical 1461065*
The use of IL6R/IL6 chimera in nerve cell regeneration
Yeda Research & Development Company 1461066*
Compsns and methods for treating hepatitis virus infection
Intermune 1461067*
Methods of compsns for normalising lipid levels in mammalian tissues
Protemix Corp 1461068*
Combined use of a GLP-1 compound and another drug for treating dyslipidaemia
Novo Nordisk 1461069*
Combined use of a GLP-1 compound and a modulator of diabetic late complications
Novo Nordisk 1461070*
Muscle transcription factors
Children's Medical Research Institute 1461071*
Proteases producing an altered immunological response and methods of making and using the same
Genencor International 1461072*
Peptide agonists of prostate-specific antigen, and uses thereof
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services 1461073*
Agents for enhancing the immune response
Becton, Dickinson & Company 1461074*
A rapid serological test for paratuberculosis using fluroescence polarisation technology
Diachemix LLC 1461075*
Methods and compsns for treating lesions of the respiratory epithelium
The General Hospital Corp 1461076*
Polyvalent immunogen
Duke University 1461077*
A peptide-based fluorescence polarisation assay for detection of antibodies to Mycobacterium bovis
Diachemix LLC 1461078*
Human immunodeficiency virus envelope glycoprotein mutants and use thereof
Progenix Pharmaceuticals 1461079*
Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
Innogenetics 1461080*
Anti-CD45RB antibodies for use in treating autoimmune disease and transplant rejection
Abgenix 1461081*
Antibodies against carboxic anhydrase IX (CA IX) tumour antigen
Abgenix 1461082*
Combined therapy against tumours comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors
Pharmacia Italia 1461083*
Guanidinium transport reagents and conjugates
The Board of Trustees of the Leland Stanford Junior University; Cellgate 1461084*
Immunoconjugates useful for treatment of tumours
Vlaams Interuniversitaur Instituut voor Biotechnologie 1461085*
Enzymatic cleavable reagents for specific delivery to disease sites
University of Wales College of Medicine 1461086*
Use of CD34+ hematopoietic progenitor cells for the treatment of CNS disorders
Institut National de la Sante et de la Recherche Medicale 1461087*
